Post Profile






Alzheimer's damage in mice reduced with compound that targets APOE gene

People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease. Now, researchers have identified a compound that targets the APOE protein in the brains of mice and protects against damage induced by the Alzheimer's protein amyloid beta. The findings indicate that APOE could potentially be a real target for treatment or prevention.
read more

share

Related Posts


NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk

Academics / General Science : Science Codex

Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National Institutes of Health h...

How Does ApoE4 Affect Alzheimer's Risk? New Clues

Health : Medical News Today

Although there is a strong association between common mutations of the ApoE gene and the risk of developing late-onset Alzheimer's disease, researchers have not known what role this gene plays in the disease until now. Of the three ...

Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target

Mental Health / Alzheimer's : ScienceDaily: Alzheimer

A new role has been identified for the major Alzheimer's risk factor ApoE4, suggesting that targeting the protein may help treat the disease. Researchers show that ApoE4 exacerbates the brain damage caused by toxic tangles of a diff...

Introducing protective variant into brain appears to halt, even reverse progression of Alzheimer's disease in mouse models

Health : Medical News Today

Carrying a particular version of the gene for apolipoprotein E (APOE) is the major known genetic risk factor for the sporadic, late-onset form of Alzheimer's disease, but exactly how that variant confers increased risk has been cont...

Alzheimer's Damage in Mice Reduced with Compound That Targets APOE Gene

Health : Newswise Medical News

People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease. Now, researchers at Washington University School of Medicine in St. Louis have identified a compound that targets the APOE protei...

Comments


Copyright © 2016 Regator, LLC